Kathy Delaria

Medicine · Health Sciences

13h-index1.4kcitations41works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(27), Multiple Myeloma Research and Treatments(19), Synthesis and Biological Evaluation(17), HER2/EGFR in Cancer Research(10), Radiopharmaceutical Chemistry and Applications(6)

Publications41 total

Supplementary Figures S1-S6 from Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
2023Open Access
Data from RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
2023Open Access
Tables and Methods from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S3 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S2 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S1 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S7 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S3 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Tables and Methods from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S4 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S1 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S4 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S2 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Data from Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
2023Open Access
Supplemetal Figures 1 and 2 from RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
2023Open Access
Figure S5 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Supplementary Figures S1-S6 from Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
2023Open Access
Data from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S6 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
Figure S5 from Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Pavel Strop(38), Arvind Rajpal(38), Russell G. Dushin(36), Santiago Farias(31), Bora Han(25), Laura Aschenbrenner(24), Kevin C. Lindquist(21), Sherman M. Chin(20), Javier Chaparro‐Riggers(20), Allison G. Chunyk(20), Bernard S. Buetow(20), Siler H. Panowski(19), Tracy C. Kuo(19), Amy Chen(19), Cris Kamperschroer(19), Edward Pascua(19), Marjorie Bateman(19), Thomas Van Blarcom(19), Yik A. Yeung(19), Michael Mirsky(19)